XML 86 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity
9 Months Ended
Sep. 30, 2014
Equity [Abstract]  
Equity
10. Equity
Common Stock
In June 2014, MetLife, Inc. announced its plans to resume common stock repurchases and repurchase up to $1.0 billion of MetLife, Inc. common stock. It is utilizing existing authorizations from the MetLife, Inc. Board of Directors to repurchase its common stock. Under these authorizations, MetLife, Inc. may purchase its common stock from the MetLife Policyholder Trust, in the open market (including pursuant to the terms of a pre-set trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934 (“Exchange Act”)) and in privately negotiated transactions.
During the nine months ended September 30, 2014, MetLife, Inc. repurchased 8,168,318 shares through open market purchases for $443 million. MetLife, Inc. did not repurchase shares during the nine months ended September 30, 2013.
At September 30, 2014, MetLife, Inc. had $818 million remaining under its common stock repurchase authorization. Future common stock repurchases will be dependent upon several factors, including our capital position, liquidity, financial strength and credit ratings, general market conditions, the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors.
See Note 15 for information about issuances of common stock related to the settlement of stock purchase contracts in October 2014.
Stock-Based Compensation Plans
Performance Shares and Performance Units
For outstanding awards granted prior to the January 1, 2013 – December 31, 2015 performance period, vested Performance Shares and Performance Units will be multiplied by a performance factor of 0.0 to 2.0 based on MetLife, Inc.’s adjusted income, total shareholder return, and performance in change in annual net operating earnings and total shareholder return compared to the performance of its competitors, each measured with respect to the applicable three-year performance period or portions thereof.
For outstanding awards granted for the January 1, 2013 – December 31, 2015 and later performance periods, the vested Performance Shares and Performance Units will be multiplied by a performance factor of 0.00 to 1.75. Assuming that MetLife, Inc. has met threshold performance goals related to its adjusted income or total shareholder return, the MetLife, Inc. Compensation Committee will determine the performance factor in its discretion. In doing so, the Compensation Committee may consider MetLife, Inc.’s total shareholder return relative to the performance of its competitors and MetLife, Inc.’s operating return on equity relative to its financial plan. The estimated fair value of Performance Shares and Performance Units will be remeasured each quarter until they become payable.
Payout of 2011 – 2013 Performance Shares
Final Performance Shares are paid in shares of MetLife, Inc. common stock. The performance factor for the January 1, 2011 – December 31, 2013 performance period was 0.80. This factor has been applied to the 1,544,120 Performance Shares associated with that performance period that vested on December 31, 2013 and, as a result, 1,235,296 shares of MetLife, Inc.’s common stock (less withholding for taxes and other items, as applicable) were issued, aside from shares that payees choose to defer, in April 2014.
Payout of 2011 2013 Performance Units
Final Performance Units are payable in cash equal to the closing price of MetLife, Inc. common stock on a date following the last day of the three-year performance period. The performance factor for the January 1, 2011 – December 31, 2013 performance period was 0.80. This factor has been applied to the 98,060 Performance Units associated with that performance period that vested on December 31, 2013 and, as a result, the cash value of 78,448 units (less withholding for taxes and other items, as applicable) was paid in April 2014.
Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., net of income tax, was as follows:

 
Three Months 
 Ended 
 September 30, 2014
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
(In millions)
Balance, beginning of period
$
13,909

 
$
476

 
$
(1,739
)
 
$
(1,588
)
 
$
11,058

OCI before reclassifications
(56
)
 
118

 
(264
)
 
28

 
(174
)
Deferred income tax benefit (expense)
130

 
(49
)
 
(157
)
 
(9
)
 
(85
)
OCI before reclassifications, net of income tax
13,983

 
545

 
(2,160
)
 
(1,569
)
 
10,799

Amounts reclassified from AOCI
(214
)
 
471

 

 
45

 
302

Deferred income tax benefit (expense)
62

 
(158
)
 

 
(13
)
 
(109
)
Amounts reclassified from AOCI, net of income tax
(152
)
 
313

 

 
32

 
193

Sale of subsidiary (2)

 

 

 

 

Deferred income tax benefit (expense)

 

 

 

 

Sale of subsidiary, net of income tax

 

 

 

 

Balance, end of period
$
13,831

 
$
858

 
$
(2,160
)
 
$
(1,537
)
 
$
10,992


 
Three Months 
 Ended 
 September 30, 2013
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
(In millions)
Balance, beginning of period
$
9,709

 
$
734

 
$
(1,825
)
 
$
(2,416
)
 
$
6,202

OCI before reclassifications
(1,437
)
 
(287
)
 
107

 
(1
)
 
(1,618
)
Deferred income tax benefit (expense)
377

 
103

 
100

 

 
580

OCI before reclassifications, net of income tax
8,649

 
550

 
(1,618
)
 
(2,417
)
 
5,164

Amounts reclassified from AOCI
95

 
(224
)
 

 
54

 
(75
)
Deferred income tax benefit (expense)
(40
)
 
70

 

 
(19
)
 
11

Amounts reclassified from AOCI, net of income tax
55

 
(154
)
 

 
35

 
(64
)
Balance, end of period
$
8,704

 
$
396

 
$
(1,618
)
 
$
(2,382
)
 
$
5,100


 
Nine Months 
 Ended 
 September 30, 2014
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
(In millions)
Balance, beginning of period
$
8,183

 
$
231

 
$
(1,659
)
 
$
(1,651
)
 
$
5,104

OCI before reclassifications
9,126

 
614

 
(486
)
 
34

 
9,288

Deferred income tax benefit (expense)
(2,851
)
 
(210
)
 
(71
)
 
(11
)
 
(3,143
)
OCI before reclassifications, net of income tax
14,458

 
635

 
(2,216
)
 
(1,628
)
 
11,249

Amounts reclassified from AOCI
(563
)
 
337

 
77

 
136

 
(13
)
Deferred income tax benefit (expense)
176

 
(114
)
 
(27
)
 
(45
)
 
(10
)
Amounts reclassified from AOCI, net of income tax
(387
)
 
223

 
50

 
91

 
(23
)
Sale of subsidiary (2)
(320
)
 

 
6

 

 
(314
)
Deferred income tax benefit (expense)
80

 

 

 

 
80

Sale of subsidiary, net of income tax
(240
)
 

 
6

 

 
(234
)
Balance, end of period
$
13,831

 
$
858

 
$
(2,160
)
 
$
(1,537
)
 
$
10,992

 
Nine Months 
 Ended 
 September 30, 2013
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
(In millions)
Balance, beginning of period
$
13,590

 
$
829

 
$
(533
)
 
$
(2,489
)
 
$
11,397

OCI before reclassifications
(6,931
)
 
(660
)
 
(1,123
)
 
1

 
(8,713
)
Deferred income tax benefit (expense)
2,296

 
221

 
38

 

 
2,555

OCI before reclassifications, net of income tax
8,955

 
390

 
(1,618
)
 
(2,488
)
 
5,239

Amounts reclassified from AOCI
(374
)
 
10

 

 
161

 
(203
)
Deferred income tax benefit (expense)
123

 
(4
)
 

 
(55
)
 
64

Amounts reclassified from AOCI, net of income tax
(251
)
 
6

 

 
106

 
(139
)
Balance, end of period
$
8,704

 
$
396

 
$
(1,618
)
 
$
(2,382
)
 
$
5,100

__________________
(1)
See Note 6 for information on offsets to investments related to insurance liabilities, DAC and VOBA and the policyholder dividend obligation.
(2)
See Note 3.
Information regarding amounts reclassified out of each component of AOCI was as follows:
AOCI Components
 
Amounts Reclassified from AOCI
 
Statement of Operations and
Comprehensive Income (Loss) Location
 
 
Three Months 
 Ended 
 September 30,
 
Nine Months 
 Ended 
 September 30,
 
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
 
(In millions)
 
 
Net unrealized investment gains (losses):
 
 
 
 
 
 
 
 
 
 
Net unrealized investment gains (losses)
 
$
181

 
$
(96
)
 
$
375

 
$
365

 
Net investment gains (losses)
Net unrealized investment gains (losses)
 
14

 
22

 
99

 
65

 
Net investment income
Net unrealized investment gains (losses)
 
33

 

 
105

 

 
Net derivative gains (losses)
OTTI
 
(14
)
 
(21
)
 
(16
)
 
(56
)
 
Net investment gains (losses)
Net unrealized investment gains (losses), before income tax
 
214

 
(95
)
 
563

 
374

 
 
Income tax (expense) benefit
 
(62
)
 
40

 
(176
)
 
(123
)
 
 
Net unrealized investment gains (losses), net of income tax
 
152

 
(55
)
 
387

 
251

 
 
Unrealized gains (losses) on derivatives - cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
1

 
3

 
28

 
17

 
Net derivative gains (losses)
Interest rate swaps
 
3

 
2

 
7

 
6

 
Net investment income
Interest rate forwards
 
(10
)
 
2

 
(8
)
 
8

 
Net derivative gains (losses)
Interest rate forwards
 

 
1

 
2

 
2

 
Net investment income
Interest rate forwards
 
1

 
(1
)
 
2

 
(2
)
 
Other expenses
Foreign currency swaps
 
(466
)
 
216

 
(368
)
 
(41
)
 
Net derivative gains (losses)
Foreign currency swaps
 
(1
)
 

 
(2
)
 
(2
)
 
Net investment income
Foreign currency swaps
 

 
1

 
1

 
1

 
Other expenses
Credit forwards
 
1

 

 
1

 
1

 
Net investment income
Gains (losses) on cash flow hedges, before income tax
 
(471
)
 
224

 
(337
)
 
(10
)
 
 
Income tax (expense) benefit
 
158

 
(70
)
 
114

 
4

 
 
Gains (losses) on cash flow hedges, net of income tax
 
(313
)
 
154

 
(223
)
 
(6
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign translation adjustment
 

 

 
(77
)
 

 
Net investment gains (losses)
Income tax (expense) benefit
 

 

 
27

 

 
 
Foreign translation adjustment, net of income tax
 

 

 
(50
)
 

 
 
Defined benefit plans adjustment: (1)
 
 
 
 
 
 
 
 
 
 
Amortization of net actuarial gains (losses)
 
(45
)
 
(71
)
 
(136
)
 
(212
)
 
 
Amortization of prior service (costs) credit
 

 
17

 

 
51

 
 
Amortization of defined benefit plan items, before income tax
 
(45
)
 
(54
)
 
(136
)
 
(161
)
 
 
Income tax (expense) benefit
 
13

 
19

 
45

 
55

 
 
Amortization of defined benefit plan items, net of income tax
 
(32
)
 
(35
)
 
(91
)
 
(106
)
 
 
Total reclassifications, net of income tax
 
$
(193
)
 
$
64

 
$
23

 
$
139

 
 
__________________
(1)
These AOCI components are included in the computation of net periodic benefit costs. See Note 12.